Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: Prevalence and associations with anemia and inflammation

Circulation: Heart Failure

Volumn 4, Issue 5, 2011, Pages 599-606

  Parikh, Ankit ^a   Natarajan, Sundar ^a,b   Lipsitz, Stuart R ^c   Katz, Stuart D ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Inflammation; Iron deficiency; Mortality

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RISK FACTOR; SELF REPORT; BLOOD; DEMOGRAPHY; INFLAMMATION; IRON DEFICIENCY ANEMIA; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NUTRITION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; UNITED STATES;

AGED; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEART FAILURE; HEMOGLOBINS; HUMANS; INFLAMMATION; IRON; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SELF REPORT; TRANSFERRIN; UNITED STATES;

EID: 84155181403     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.960906     Document Type: Article

References (44)

1. Jelani Q, Attanasio P, Katz SD, Anker SD. Treatment with iron of patients with heart failure with and without anemia. Heart Fail Clin. 2010;6:305-312.
2. Failla ML. Trace elements and host defense: recent advances and continuing challenges. J Nutr. 2003;133:1443S-1447S. (Pubitemid 36548722)
3. Gordeuk VR, Bacon BR, Brittenham GM. Iron overload: causes and consequences. Annu Rev Nutr. 1987;7:485-508.
4. Beard JL. Iron biology in immune function, muscle metabolism, and neuronal functioning. J Nutr. 2001;131:568S-580S. (Pubitemid 32117681)
5. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113:2454-2461. (Pubitemid 43948053)
6. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray J, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872-1880.
7. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol. 2006;48:1225-1227. (Pubitemid 44345150)
8. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007;50:1657-1665. (Pubitemid 47562670)
9. Okonko DO, Grzeslo A, Witkowski T, Mandal A, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008;51:103-112.
10. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol. 2008;21:236-242.
11. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-2448.
12. Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. US Department of Health and Human Services, National Center for Health Statistics. http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed January 3, 2011.
13. National Center for Health Statistics. Office of Analysis and Epidemiology, Public-use Third National Health and Nutrition Examination Survey Linked Mortality File, 2007. Hyattsville, MD. http://www.cdc.gov/nchs/data- access/data-linkage/mortality/nhanes3-linkage-public-use.htm. Accessed January 3, 2011.
14. NHLBI Obesity Education Initiative Expert Panel. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855-1867.
15. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology. 2002;13:561-568.
16. Gunter EW, Lewis BG, Koncikowski SM. US Department of Health and Human Services. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. http://www.cdc.gov/nchs/data/ nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf. Accessed January 3, 2011.
17. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. (World Health Organization) Revision, Volume 1. 1992.
18. SAS/STAT User's Guide, Version 9.2. Cary, NC: SAS Institute Inc; 2008.
19. Mukhopadhyay PK. Not Hazardous to Your Health: Proportional Hazards Modeling for Survey Data with the SURVEYPHREG Procedure. SAS Global Forum Proceedings: Statistics and Data Analysis. Seattle, WA, 2010:1-13.
20. SAS Institute Inc. Chapter 14. Introduction to Survey Sampling and Analysis Procedures. SAS/STAT 9.2 User's Guide. Cary, NC: SAS Publishing; 2008.
21. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-962. (Pubitemid 32912694)
22. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-1939. (Pubitemid 36677110)
23. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity, and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786. (Pubitemid 34595288)
24. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-119. (Pubitemid 36183592)
25. Maggioni AP, Opasich C, Anand I, Barlera S, Carbonieri E, Gonzini L, Tavazzi L, Latini R, Cohn J. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail. 2005;11:91-98. (Pubitemid 40269782)
26. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12, 065 patients with new-onset heart failure. Circulation. 2003;107:223-225. (Pubitemid 36135214)
27. Mueller C, Laule-Killian K, Christ A, Brunner-La Rocca HP, Perruchoud AP. Inflammation and long-term mortality in acute congestive heart failure. Am Heart J. 2006;151:845-850.
28. Chirinos JA, Zambrano JP, Chakko S, Schob A, Veerani A, Perez GO, Mendez AJ. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Am J Cardiol. 2005;95:88-90. (Pubitemid 40051115)
29. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN, for the Val-HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation. 2005;112:1428-1434. (Pubitemid 41291768)
30. Araujo JP, Lourenco P, Azevedo A, Frioes F, Rocha-Goncalves F, Ferreira A, Bettencourt P. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail. 2009;15:256-266.
31. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J. 2004;147:924-930. (Pubitemid 38881010)
32. Westenbrink BD, Voors AA, van Veldhuisen DJ. Is anemia in chronic heart failure caused by iron deficiency? J Am Coll Cardiol. 2007;49:2301-2302. (Pubitemid 46856817)
33. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJ. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J. 2006;151:1313-1321. (Pubitemid 43866609)
34. Anand IS. Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol. 2008;52:501-511.
35. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.
36. Anand IS, Rector T, Deswal A. Relationship between proinflammatory cytokines and anemia in heart failure. Eur Heart J. 2006;27:485.
37. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-2395.
38. Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
39. Jelani Q, Katz SD. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease. Cardiol Rev. 2010;18:240-250.
40. Yuan XM, Li W. Iron involvement in multiple signaling pathways of atherosclerosis: a revisited hypothesis. Curr Med Chem. 2008;15:2157-2172.
41. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ. 1997;314:793-794. (Pubitemid 27117051)
42. Meyers DG, Strickland D, Maloney PA, Seburg JK, Wilson JE, McManus BF. Possible association of a reduction in cardiovascular events with blood donation. Heart. 1997;78:188-193. (Pubitemid 27404957)
43. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and the risk of coronary heart disease in men. Circulation. 2001;103:52-57. (Pubitemid 32050435)
44. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion. 2002;42:1135-1139.